logo
  

Gilead: Trodelvy Extends Overall Survival In Second-Line Metastatic TNBC - Quick Facts

Gilead Sciences, Inc. (GILD) reported final data from the phase 3 ASCENT study of Trodelvy in patients with relapsed or refractory metastatic triple-negative breast cancer who received two or more prior systemic therapies, at least one of them for metastatic disease. In a follow-up analysis from the final database lock, Trodelvy improved median progression-free survival versus physicians' choice of chemotherapy and extended median overall survival by almost five months in the intent-to-treat population. The company noted that the safety profile of Trodelvy was consistent with prior reports.

Bill Grossman, Senior Vice President, Therapeutic Area Head, Gilead Oncology, said: "These final data from ASCENT reinforce Trodelvy as a new standard-of-care option in this setting."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said it now intends to review only a small subset of new emergency use authorization or EUA requests for diagnostic tests. As per an updated COVID-19 test policy with a view to ensure continued access to tests, the regulator further urged developers of all test types seeking marketing authorization to pursue traditional premarket review for most test types. Netflix, Inc. said it is adding a new feature to offer a more personalized mobile games experience on the platform. In a statement, Sophia Yang, Product Manager, Mobile Games, said the company is rolling out the ability to create game handles, with which members will be able to create a unique public username. This can be used across all Netflix games. General Motors Co. has delayed its plan to require employees to return to office many days a week until next year, reports said citing an internal memo signed by CEO Mary Barra. Last week, the company had announced that corporate workers would be required to return to respective offices at least three days a week, beginning later this year, as the COVID-19 pandemic eases.
Follow RTT